Hospital supply of medicines to in-patients not considered 'sale of goods' under Kerala VAT Act

The court held that the supply of medicines, implants, and consumables by hospitals to in-patients during medical treatment does not amount to a 'sale of goods' under the Kerala Value Added Tax Act. It emphasized that such transactions are part of the overall service of providing medical care, following the dominant nature test. The court distinguished these transactions from taxable sales under Article 366(29A) and overturned previous decisions suggesting otherwise. The matter was referred back to the Division Bench for case-specific review.

---

---

Issues Involved:
1. Whether the supply of medicines, implants, consumables, and surgical tools used in hospital treatments constitutes a 'sale of goods' under the Kerala Value Added Tax Act, 2003 (KVAT Act).

Issue-wise Detailed Analysis:

1. Supply of Medicines, Implants, Consumables, and Surgical Tools as 'Sale of Goods':
The central question referred for consideration was whether the supply of medicines, implants, consumables, and surgical tools used in hospital treatments, billed to patients, constitutes a 'sale of goods' under the KVAT Act. The Division Bench initially opined that such transactions form part of the services rendered by the hospital and are not exigible to tax under the sales tax enactment. This view was in conflict with previous decisions of the court, necessitating a reference.

2. Legal Precedents and Interpretations:
The court reviewed various decisions, including Malankara Orthodox Syrian Church v. Sales Tax Officer, where it was held that hospitals are 'dealers' under the Kerala General Sales Tax Act, 1963 (KGST Act), and the supply of medicines is an integral part of the treatment. The court noted that the legislative intent was to cover sales effected in the course of rendering services. However, the dominant nature test, as discussed in Bharat Sanchar Nigam Ltd. v. Union of India, was emphasized, indicating that the primary nature of transactions in hospitals is service-oriented, not sales.

3. Dominant Nature Test and Article 366(29A):
The court reiterated that the dominant nature test applies to composite transactions not covered by Article 366(29A) of the Constitution. It was emphasized that the sale of drugs, implants, and consumables in hospitals is part of the medical treatment service and does not create separate rights on such items. The dominant intention in hospital services is the provision of medical care, not the sale of goods.

4. Legislative Intent and Constitutional Amendments:
The court examined the legislative intent behind Article 366(29A), which introduced deemed sales for specific transactions like works contracts, hire-purchase contracts, and catering contracts. It was clarified that this amendment does not extend to hospital services. The supply of medicines in hospitals is an inseparable part of the medical service and cannot be taxed separately as a sale of goods.

5. Applicability of Previous Court Decisions:
The court reviewed decisions from other High Courts, such as International Hospital Pvt. Ltd. v. State of U.P., Fortis Health Care Limited v. State of Punjab, and Tata Main Hospital v. State of Jharkhand, which held that the supply of medicines and consumables in hospitals is part of the service rendered and not taxable as a sale of goods. These decisions aligned with the court's interpretation.

Conclusion:
The court concluded that the supply of medicines, implants, and consumables by hospitals to in-patients in the course of medical treatment cannot be separated from the composite, indivisible service of providing medical care and treatment. Such transactions do not constitute a 'sale of goods' under Article 366(29A) of the Constitution. The previous decisions in Malankara Orthodox Syrian Church and related cases were found to be incorrect in law. The matters were directed to be placed before the Division Bench for consideration of individual cases.

---